Literature DB >> 16094247

The short/long polymorphism in the serotonin transporter gene promoter is not associated with panic disorder in a Scandinavian sample.

Ole F Olesen1, Bente Bennike, Elsebet S Hansen, Pernille Koefoed, David P Woldbye, Tom G Bolwig, Erling Mellerup.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16094247     DOI： 10.1097/00041444-200509000-00003

Source DB:  PubMed          Journal:  Psychiatr Genet        ISSN： 0955-8829            Impact factor:   2.458


× No keyword cloud information.
  8 in total

Review 1.  Candidate genes in panic disorder: meta-analyses of 23 common variants in major anxiogenic pathways.

Authors:  A S Howe; H N Buttenschøn; A Bani-Fatemi; E Maron; T Otowa; A Erhardt; E B Binder; N O Gregersen; O Mors; D P Woldbye; K Domschke; A Reif; J Shlik; S Kõks; Y Kawamura; A Miyashita; R Kuwano; K Tokunaga; H Tanii; J W Smoller; T Sasaki; D Koszycki; V De Luca
Journal:  Mol Psychiatry       Date:  2015-09-22       Impact factor: 15.992

2.  Determinants of pharmacodynamic trajectory of the therapeutic response to paroxetine in Japanese patients with panic disorder.

Authors:  Shin Ishiguro; Takashi Watanabe; Mikito Ueda; Yoshinori Saeki; Yuki Hayashi; Kazufumi Akiyama; Atsushi Saito; Kazuko Kato; Yoshimasa Inoue; Kazutaka Shimoda
Journal:  Eur J Clin Pharmacol       Date:  2011-06-19       Impact factor: 2.953

3.  Elevated tph2 mRNA expression in a rat model of chronic anxiety.

Authors:  Nina C Donner; Philip L Johnson; Stephanie D Fitz; Karen E Kellen; Anantha Shekhar; Christopher A Lowry
Journal:  Depress Anxiety       Date:  2012-04       Impact factor: 6.505

4.  Association of a polyadenylation polymorphism in the serotonin transporter and panic disorder.

Authors:  Sandeep Gyawali; Ryan Subaran; Myrna M Weissman; Dylan Hershkowitz; Morgan C McKenna; Ardesheer Talati; Abby J Fyer; Priya Wickramaratne; Phillip B Adams; Susan E Hodge; Carl J Schmidt; Michael J Bannon; Charles E Glatt
Journal:  Biol Psychiatry       Date:  2009-12-06       Impact factor: 13.382

5.  Genetic and pharmacokinetic factors affecting the initial pharmacotherapeutic effect of paroxetine in Japanese patients with panic disorder.

Authors:  Yoshinori Saeki; Takashi Watanabe; Mikito Ueda; Atsushi Saito; Kazufumi Akiyama; Yoshimasa Inoue; Genta Hirokane; Sachiyo Morita; Naoto Yamada; Kazutaka Shimoda
Journal:  Eur J Clin Pharmacol       Date:  2009-03-04       Impact factor: 2.953

6.  Lack of association between the Serotonin Transporter Promoter Polymorphism (5-HTTLPR) and Panic Disorder: a systematic review and meta-analysis.

Authors:  Carolina Blaya; Giovanni A Salum; Maurício S Lima; Sandra Leistner-Segal; Gisele G Manfro
Journal:  Behav Brain Funct       Date:  2007-08-18       Impact factor: 3.759

7.  Genetic Polymorphism of 1019C/G (rs6295) Promoter of Serotonin 1A Receptor and Catechol-O-Methyltransferase in Panic Disorder.

Authors:  Takashi Watanabe; Shin Ishiguro; Akiko Aoki; Mikito Ueda; Yuki Hayashi; Kazufumi Akiyama; Kazuko Kato; Kazutaka Shimoda
Journal:  Psychiatry Investig       Date:  2016-12-29       Impact factor: 2.505

8.  Early Improvement and Marriage Are Determinants of the 12-Month Treatment Outcome of Paroxetine in Outpatients with Panic Disorder.

Authors:  Takashi Watanabe; Mikito Ueda; Shin Ishiguro; Yuki Hayashi; Akiko Aoki; Masataka Shinozaki; Kazuko Kato; Kazufumi Akiyama; Kazutaka Shimoda
Journal:  Clin Psychopharmacol Neurosci       Date:  2017-11-30       Impact factor: 2.582
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.